Proteinuria clinical trials

The registry lists 328 studies for Proteinuria across more than 10 countries. 44 are recruiting or about to start. 71 of them are mainly about Proteinuria (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09. Counting its 2 narrower conditions too, such as Albuminuria: 460 studies, 66 open.

Get an email when these change. Save the Proteinuria studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 179
Status unknown: 50
Recruiting: 31
Terminated: 29
Withdrawn: 16
Not yet recruiting: 10

Phase

Phase 2: 74
Phase 4: 68
Phase 3: 55
Phase 1: 14
Early Phase 1: 2

Where

United States: 125
China: 40
Italy: 30
Canada: 25
Germany: 24
United Kingdom: 23

Who runs them

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (15) · Novartis Pharmaceuticals (10) · Gulhane School of Medicine (5) · Medical University of Gdansk (5) · Mario Negri Institute for Pharmacological Research (5) · Odense University Hospital (4) · AstraZeneca (4) · Children's Hospital of Fudan University (4)

What is being tested here

Drugs under test in Proteinuria studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Iptacopan	3	4	4
Huaier Extract Granule	2	0	3
Empagliflozin	2	2	3
JADE101	2	1	2
Losartan	1	5	15
Dapagliflozin	1	1	6
Rituximab	1	2	6
Mycophenolic Acid	1	2	5
Cyclosporine	1	0	4
Amiloride	1	0	4

Drug classes tested here Angiotensin receptor blockers (ARBs) 2 open · SGLT2 inhibitors 2 open · Diuretics 2 open · Endothelin receptor antagonists 2 open · Mineralocorticoid receptor antagonists (MRAs) 1 open

Coming up

14phase 3 studies under way

18studies finish main data collection within a year4 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Dec 2026The Efficacy and Safety of Dapagliflozin in the Treatment of Hereditary Kidney Disease With Proteinuria in Children · Phase 3 · Children's Hospital of Fudan University
Jan 2027Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy. · Phase 3 · Novartis Pharmaceuticals
Apr 2027A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria · Phase 3 · Bayer
Oct 2027FINEPKT - Finerenone in Proteinuria Patients After Kidney Transplan · Phase 3 · kewen Chen,MD
Nov 2026Kidney Health: Eat Well, Live Well · University of Texas at Austin
Nov 2026Proteinuria in Pre and Post Transplant · University of Miami
Dec 2026Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE) · Wake Forest University Health Sciences
Dec 2026Sparsentan for the Treatment of VEGF Signaling Pathway Inhibitor-Associated Proteinuria · Brigham and Women's Hospital
Dec 2026Nefecon and Ambrisentan in IgA Nephropathy · The First Hospital of Jilin University
Jan 2027A Smart Phone Application to Improve Adoption of the 2024 Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease (CKD) Guidelines · St. James's Hospital, Ireland

Who these studies take

Of the 31 Proteinuria studies recruiting now, 11 (35%) set no upper age limit and 16 (52%) stop at 75 or younger. 12 (39%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 3 (10%) take healthy volunteers.

Recruiting studies that take each age, of 31
Age	Women	Men
10	8 (26%)	8 (26%)
18	29 (94%)	29 (94%)
30	23 (74%)	23 (74%)
40	22 (71%)	22 (71%)
50	22 (71%)	22 (71%)
65	19 (61%)	19 (61%)
75	16 (52%)	16 (52%)
85	15 (48%)	15 (48%)

Across all 328 studies, recruiting or not: 47% stop at 75 or younger and 27% at 65; 20% take children; 6% are for women only and 1% for men only; 13% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Proteinuria studies take

Of 25 phase 2 interventional studies under Proteinuria, half reached primary completion within 29 months of starting, counting those still running.

Start to primary completion	Every sponsor	Industry	Non-industry
Phase 2	29 mo17–52 · 25 studies	—	—
Phase 3	64 mo21–78 · 20 studies	—	—
Observational	62 mo20–… · 22 studies	—	—

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 12, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 328. Browse all 328 → or search them.